On February 2, 2022 EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, reported that both Intouch Group, an EVERSANA company and EVERSANA ENGAGE have been named winners in the 2021 PM360 Pharma Choice Awards (Press release, EVERSANA, FEB 2, 2022, View Source [SID1234607619]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Entries from Intouch Group earned gold in the professional campaign category, as well as two silver recognitions in the multichannel and variety categories. EVERSANA ENGAGE earned a silver award for work with Evoke Pharma and the "Spray Your Symptoms Away" campaign which promotes Gimoti (metoclopramide) nasal spray for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
The marketing campaign highlights the novel route administration of GIMOTI to address a problematic disease where oral therapies aren’t properly absorbed due to delayed stomach emptying. It is part of EVERSANA’s integrated suite of outsourced services to commercialize and distribute GIMOTI in the United States.
"It’s tremendous to be recognized by PM360," said Jim Lang, CEO at EVERSANA. "The combined creative team at both Intouch Group and EVERSANA ENGAGE demonstrate the power of our ability to deliver world-class, impactful campaigns that help connect patients with life changing therapies. Congrats to everyone from both teams on this achievement."
PM360 is a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Since 2009, the PM360 Pharma Choice awards have served as the only industry awards to recognize outstanding achievement and creativity in healthcare and life sciences marketing by allowing the industry to choose the winners.
All submissions are placed online, and anyone in the industry can vote for their favorites based on content, format, imagination, influence on the industry, impact on the audience, and overall quality. This year, more than 8,000 votes were cast. Thirty-nine winners across 13 categories are featured in the most recent issue of PM360 magazine.
EVERSANA acquired Intouch Group in December 2021. Agencies from both firms will integrate, as EVERSANA ENGAGE joins forces with the Intouch agency network in 2022.